Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure. The pacing therapy.

C Pappone1, V Santinelli

  • 1Division of Arrhythmology, University Hospital San Raffaele, Milan, Italy. carlo.pappone@hrs.it

Minerva Cardioangiologica
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An update on atrial fibrillation in 2014: From pathophysiology to treatment.

International journal of cardiology·2015
Same author

Cardiac electrophysiology in diabetes.

Minerva cardioangiologica·2010
Same author

[Epicardial ablation of atrial fibrillation during heart valve surgery].

Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·2009
Same author

Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction.

Heart (British Cardiac Society)·2006
Same author

Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy.

Obstetrics and gynecology·2003
Same author

[Electrophysiological bases of atrial fibrillation].

Cardiologia (Rome, Italy)·2002
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Cardiac resynchronization therapy offers improved survival for congestive heart failure (CHF) patients. While effective for some, its variability and investigational status highlight the need for ongoing research into pacing strategies for severe CHF.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Standard medical therapies for congestive heart failure (CHF) improve survival but often fail to enhance quality of life.
  • Cardiac pacing, particularly biventricular pacing, has emerged as a complementary treatment for severe CHF since the 1990s.
  • Biventricular pacing aims to improve ventricular synchrony in CHF patients with left bundle branch block (LBBB).

Purpose of the Study:

  • To review the current status and evolving technology of cardiac pacing in managing congestive heart failure.
  • To discuss the efficacy and limitations of biventricular pacing and explore novel pacing strategies.
  • To highlight ongoing research and future directions for pacing therapies in CHF.

Main Methods:

  • Review of clinical trials and technological advancements in cardiac pacing for CHF.

Related Experiment Videos

  • Analysis of left ventricular lead placement success rates and complication profiles.
  • Discussion of emerging pacing modalities like contractility modulation.

    • Main Results:

    • Biventricular pacing has shown promise in improving ventricular activation and contraction efficiency in selected CHF patients.
    • Left ventricular lead implantation success rates have significantly increased with technological improvements.
    • Patient response to pacing therapy is highly variable, indicating limitations of current strategies.

    Conclusions:

    • Cardiac resynchronization therapy (CRT) is a developing field with ongoing trials to define its impact on morbi-mortality.
    • Current pacing strategies for CHF, while showing encouraging short-term results, remain largely investigational.
    • Novel pacing approaches like contractility modulation may broaden therapeutic options for CHF patients.